Cave Consulting Group (“CCGroup”) Develops Acceptable Clinical Protocol Range for Upper GI Endoscopy Use in Treating Gastroesophageal (GERD)
February 22, 2013
San Mateo, CA. – CCGroup is pleased to announce that the company has developed an acceptable clinical protocol range for utilizing upper gastrointestinal (GI) endoscopies in treating routine, noncomplicated GERD (or heartburn) patient episodes-of-care. CCGroup BullsEye™ statistical analysis and methodologies (protected by U.S. Patent No. 8,301,464) strongly correlates upper GI endoscopies as the key procedure to gastroenterologists’ efficiency score in treating noncomplicated GERD. Therefore, upper GI endoscopy is the MedMarker™ (or correlated service) in treating non-complicated GERD. Continue reading
